HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Yoshikawa Selected Research

Molecular Targeted Therapy

4/2009Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Yoshikawa Research Topics

Disease

3Cholangiocarcinoma
06/2011 - 01/2008
2Neoplasm Metastasis (Metastasis)
04/2009 - 01/2008
1Chronic Kidney Failure (Chronic Renal Failure)
05/2012
1Neoplasms (Cancer)
04/2009
1Lymphatic Metastasis
01/2008
1Brain Ischemia (Cerebral Ischemia)
01/2005
1Ischemia
01/2005
1Hydrothorax
09/2001

Drug/Important Bio-Agent (IBA)

2ErbB Receptors (EGF Receptor)IBA
04/2009 - 01/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2009 - 01/2008
1Oncogene Proteins (Oncogene Protein)IBA
06/2011
1vandetanib (ZD6474)IBA
04/2009
1human ERBB2 proteinIBA
01/2008
1Prion ProteinsIBA
01/2005
1Proteins (Proteins, Gene)FDA Link
01/2005

Therapy/Procedure

2Therapeutics
05/2012 - 04/2009
1Molecular Targeted Therapy
04/2009
1Uterine Myomectomy
09/2001